{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03523377",
            "orgStudyIdInfo": {
                "id": "18-199"
            },
            "organization": {
                "fullName": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Overnight Fasting After Completion of Therapy: The OnFACT Study",
            "officialTitle": "Overnight Fasting After Completion of Therapy: The OnFACT Study",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "overnight-fasting-after-completion-of-therapy-the-onfact-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-04-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-05-01",
            "studyFirstSubmitQcDate": "2018-05-01",
            "studyFirstPostDateStruct": {
                "date": "2018-05-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-18",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Rockefeller University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to test whether regularly not eating for at least 14 hours overnight (\"intermittent fasting\") is feasible and can improve blood sugar."
        },
        "conditionsModule": {
            "conditions": [
                "Childhood Cancer Survivors"
            ],
            "keywords": [
                "Fasting",
                "18-199"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "The OnFACT study is a pilot randomized controlled trial of prolonged overnight fasting among adult survivors of childhood cancer.",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "prolonged overnight fasting",
                    "type": "EXPERIMENTAL",
                    "description": "Participants randomized to the fasting arm will be instructed on how to use the SMS texting app to indicate the beginning and end of the nightly fast. In the first 2-4 weeks following the first overnight fast, intervention participants will complete three phone calls with study staff trained in motivational interviewing. These calls will be used to reinforce the prolonged overnight fasting instructions, identify barriers to prolonged overnight fasting, and support successes where they have occurred.",
                    "interventionNames": [
                        "Other: prolonged overnight fasting"
                    ]
                },
                {
                    "label": "usual care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants randomized to the usual care arm will be instructed to eat a heart-healthy diet and exercise for at least 30 minutes five days a week, which is usual counseling in our clinics.",
                    "interventionNames": [
                        "Other: usual care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "prolonged overnight fasting",
                    "description": "Three phone calls using motivational interviewing, support via SMS text.",
                    "armGroupLabels": [
                        "prolonged overnight fasting"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "usual care",
                    "description": "Eat a heart-healthy diet and exercise for at least 30 minutes five days a week",
                    "armGroupLabels": [
                        "usual care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Participation completion",
                    "description": "Proportion of registered participants who successfully complete the 6-month intervention",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "measure of glucose metabolism",
                    "description": "Assess the effect of prolonged overnight fasting on glucose metabolism, measured by glycosylated hemoglobin (HbA1c).",
                    "timeFrame": "6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Body mass index is \u2265 18.5 kg/m\\^2\n* History of treatment for cancer or related illness diagnosed at \u2264 25 years old\n* Off cytotoxic therapy for primary cancer \u2265 2 years\n* Not receiving cytotoxic therapy (chemotherapy, external beam radiation therapy) at the time of study enrollment\n* History of radiation to the chest, abdomen or total body\n* Current age \u226518 years\n* English-speaking\n* Personal phone with SMS text messaging capability\n* Willingness to wear an mHealth device, such as a FitBit, for two 7-day periods\n* Able to perform all study requirements\n\nExclusion Criteria:\n\n* Use of any antidiabetic, weight loss, or appetite control medication\n* Use of any other medication that could impact dietary intake, such as prednisone\n* Currently fasts 12 hours or more by self-report\n* Unable to fast due to medical reason such as pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Danielle Friedman, MD, MS",
                    "role": "CONTACT",
                    "phone": "212-639-7376",
                    "email": "friedmad@mskcc.org"
                },
                {
                    "name": "Chaya Moskowitz, PhD",
                    "role": "CONTACT",
                    "phone": "646-888-8232"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Danielle Friedman, MD, MS",
                    "affiliation": "Memorial Sloan Kettering Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Danielle Friedman, MD, MS",
                            "role": "CONTACT",
                            "phone": "212-639-7376"
                        },
                        {
                            "name": "Danielle Friedman, MD, MS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Memorial Sloan Kettering Cancer Center",
                    "url": "http://www.mskcc.org/mskcc/html/44.cfm"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}